Latest
 
  • All Share : 52690.98
    UP 1.77%
    Top40 - (Tradeable) : 46074.35
    UP 1.86%
    Financial 15 : 14976.41
    UP 1.66%
    Industrial 25 : 69539
    UP 1.21%
    Resource 10 : 32525.83
    UP 4.02%

  • ZAR/USD : 13.7699
    UP 1.07%
    ZAR/GBP : 17.8339
    UP 0.74%
    ZAR/EUR : 15.4265
    UP 0.97%
    ZAR/JPY : 0.1351
    UP 0.22%
    ZAR/AUD : 10.5374
    UP 0.63%

  • Gold US$/oz : 1321.5
    UP 0.01%
    Platinum US$/oz : 1028
    UP 0.10%
    Silver US$/oz : 19.11
    DOWN -0.31%
    Palladium US$/oz : 708
    DOWN -0.28%
    Brent Crude : 48.4
    DOWN -0.88%

  • All data is delayed by 15 min. Data supplied by Profile Data
    Hover cursor over this ticker to pause.

Thu Sep 29 12:11:40 CAT 2016

One person brain-dead, five hospitalised after French drug trial mishap: minister

AFP | 15 January, 2016 13:21
French Health Minister Marisol Touraine. File photo
Image by: CHARLES PLATIAU / REUTERS

A "serious accident" during a drugs trial in France has left one person brain-dead and five hospitalised, Health Minister Marisol Touraine said.

She said the six had been taking part in a "trial of an oral medication being developed by a European laboratory" in Rennes, northwest France.

Media reports said the drug was a cannabis-based painkiller, but this was denied by the health ministry.

"A serious accident took place," the minister said, adding the study had been halted and all volunteers taking part recalled.

The study was a phase one clinical trial, in which healthy volunteers take the medication to "evaluate the safety of its use, tolerance and pharmacological profile of the molecule", the minister added in a statement.

Medical trials typically have three phases to assess a new drug or device for safety and effectiveness.

Phase I entails a small group of volunteers, and focuses only on safety.

Phase II and Phase III are progressively larger trials to assess the drug's effectiveness, although safety remains paramount.

The Paris prosecutor's office said an investigation had been opened.

Touraine said she was determined to "shed light on" what happened.

SHARE YOUR OPINION

If you have an opinion you would like to share on this article, please send us an e-mail to the Times LIVE iLIVE team. In the mean time, click here to view the Times LIVE iLIVE section.